Mogrify Company

Mogrify® will transform the development of ex vivo cell therapies and pioneer a new class of in vivo reprogramming therapies.


Connections from

Technology: AgeTech Companies, Cell therapy
Industry: Healthcare, Private
Headquarters: Cambridge, Cambridgeshire, United Kingdom
Founded Date: 2019-01-01
Employees Number: 101-250
Funding Status: Early Stage Venture
Investors Number: 8
Total Funding: 37800000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-09-03
Last Funding Type: Series A

Visit Website
Register and Claim Ownership